Action Bausch Health Companies - BVF

Bausch Health Companies Inc (BVF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

4,198

( - )

Prix Achat

4,112

Prix Vente

4,19

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

4,10 Plage de 52 semaines 7,499

Clôture Veille

4,198

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

1 163

Volume financier

VWAP

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that Mark K. Oki has been...

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

* Biovail Shareholders Asked to Support Two Independent Directors That are Not Tied to Management or to Eugene Melnyk * TORONTO, May 11...

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) today announced that it has entered into an...

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC Investigation of...

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Nov. 21 /PRNewswire/ -- The...

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and Financial...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.5	-10.6428267348	4.698	4.95	4.0999999	2216	4.21953068	DE
4	-0.016	-0.379686758424	4.214	4.95	4.0999999	1392	4.33103663	DE
12	-0.452	-9.72043010753	4.65	5.235	4.0999999	1163	4.57719901	DE
26	-1.812	-30.149750416	6.01	6.867	4.0999999	2163	5.04107826	DE
52	-1.503	-26.3637958253	5.701	7.499	4.0999999	2658	5.60962503	DE
156	-3.586	-46.0688591984	7.784	9.893	3.7235	2191	5.84901121	DE
260	-3.586	-46.0688591984	7.784	9.893	3.7235	2191	5.84901121	DE

BVF - Frequently Asked Questions (FAQ)

What is the current Bausch Health Companies Inc share price?

The current share price of Bausch Health Companies Inc is 4,198 €

What is the 1 year trading range for Bausch Health Companies Inc share price?

Bausch Health Companies Inc has traded in the range of 4,10 € to 7,499 € during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bausch Health Companies Inc (BVF)

Bausch Health Companies Inc (BVF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

BVF Dernières nouvelles

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

/ C O R R E C T I O N -- Scott + Scott, LLC /

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Biovail Reports Third Quarter 2003 Financial Results - Correction

BVF - Frequently Asked Questions (FAQ)

BVF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bausch Health Companies Inc (BVF)

Bausch Health Companies Inc (BVF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

BVF Dernières nouvelles

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

/ C O R R E C T I O N -- Scott + Scott, LLC /

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Biovail Reports Third Quarter 2003 Financial Results - Correction

BVF - Frequently Asked Questions (FAQ)

BVF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités